Gray Kelly, Pacey Verity, Gibbons Paul, Little David, Frost Chris, Burns Joshua
Department of Physiotherapy, The Children’s Hospital at Westmead, Westmead,
Cochrane Database Syst Rev. 2012 Apr 18(4):CD008602. doi: 10.1002/14651858.CD008602.pub2.
Congenital talipes equinovarus (CTEV), which is also known as clubfoot, is a common congenital orthopaedic condition. It is characterised by an excessively turned in foot (equinovarus) and high medial longitudinal arch (cavus). If left untreated it can result in long-term disability, deformity and pain. Interventions can be conservative (such as splinting or stretching) or surgical.
To evaluate the effectiveness of interventions for CTEV.
We searched CENTRAL (2011, Issue 2), NHSEED (2011, Issue 2), MEDLINE (January 1966 to April 2011), EMBASE (January 1980 to April 2011), CINAHL Plus (January 1937 to April 2011), AMED (1985 to April 2011) and the Physiotherapy Evidence Database (PEDro to April 2011). We checked the references of included studies.
Randomised and quasi-randomised controlled trials evaluating interventions for CTEV. Participants were people of all ages with CTEV of either one or both feet.
Two authors independently assessed risk of bias in included trials and extracted the data. We contacted authors of included trials for missing information. We collected adverse event information from trials when it was available.
We identified 13 trials in which there were 507 participants. The use of different outcome measures prevented pooling of data for meta-analysis even when interventions and participants were comparable. All trials displayed bias in four or more areas. One trial reported on the primary outcome of function, though raw data were not available to be analysed. We were able to analyse data on foot alignment (Pirani score), a secondary outcome, from three trials. The Pirani score is scored from zero to six, in which higher is worse. Two of the trials involved participants at initial presentation. One of them reported that the Ponseti technique significantly improved foot alignment compared to the Kite technique. After 10 weeks of serial casting, the average total Pirani score of the Ponseti group was 1.15 (95% confidence interval 0.98 to 1.32) lower than that of the Kite group. The second trial found the Ponseti technique to be superior to a traditional technique, with average total Pirani scores of the Ponseti participants 1.50 lower (95% confidence interval 0.72 to 2.28) after serial casting and Achilles tenotomy. A trial in which the type of presentation was not reported found no difference between an accelerated Ponseti or standard Ponseti treatment. At the end of serial casting, the average total Pirani scores in the standard group were 0.31 lower (95% confidence interval -0.40 to 1.02) than the accelerated group. Adverse events were not compared in the trial. There is a lack of evidence for different plaster casting products or the addition of botulinum toxin A during the Ponseti technique. There is also a lack of evidence for different types of major foot surgery for CTEV, continuous passive motion treatment following major foot surgery, or treatment of relapsed or neglected cases of CTEV. Most trials did not report on adverse events. In trials evaluating serial casting techniques, adverse events included cast slippage (needing replacement), plaster sores (pressure areas) and skin irritation. Adverse events following surgical procedures included infection and the need for skin grafting.
AUTHORS' CONCLUSIONS: From the limited evidence available, the Ponseti technique may produce better short-term outcomes compared to the Kite technique. An accelerated Ponseti technique may be as effective as a standard technique. We could draw no conclusions from other included trials because of the limited use of validated outcome measures and lack of available raw data. Future randomised controlled trials should address these issues.
先天性马蹄内翻足(CTEV),又称畸形足,是一种常见的先天性骨科疾病。其特征为足部过度内翻(马蹄内翻)和高内侧纵弓(高弓足)。若不治疗,可导致长期残疾、畸形和疼痛。干预措施可分为保守治疗(如夹板固定或拉伸)或手术治疗。
评估先天性马蹄内翻足干预措施的有效性。
我们检索了Cochrane系统评价数据库(CENTRAL,2011年第2期)、英国国家卫生与临床优化研究所卫生经济评价数据库(NHSEED,2011年第2期)、医学文献数据库(MEDLINE,1966年1月至2011年4月)、荷兰医学文摘数据库(EMBASE,1980年1月至2011年4月)、护理学与健康领域数据库(CINAHL Plus,1937年1月至2011年4月)、联合和补充医学数据库(AMED,1985年至2011年4月)以及物理治疗证据数据库(PEDro至2011年4月)。我们还检查了纳入研究的参考文献。
随机和半随机对照试验,评估先天性马蹄内翻足的干预措施。参与者为所有年龄的单足或双足先天性马蹄内翻足患者。
两位作者独立评估纳入试验的偏倚风险并提取数据。我们联系了纳入试验的作者以获取缺失信息。当试验提供不良事件信息时,我们收集了这些信息。
我们确定了13项试验,共507名参与者。即使干预措施和参与者具有可比性,不同结局指标的使用也妨碍了对数据进行荟萃分析。所有试验在四个或更多领域存在偏倚。一项试验报告了功能的主要结局,但未提供可分析的原始数据。我们能够分析来自三项试验的足部对线(皮拉尼评分)这一次要结局的数据。皮拉尼评分从0到6分,分数越高情况越差。其中两项试验纳入了初诊参与者。其中一项试验报告称,与凯泰技术相比,庞塞蒂技术显著改善了足部对线。经过10周的连续石膏固定后,庞塞蒂组的平均皮拉尼总分比凯泰组低1.15分(95%置信区间0.98至1.32)。第二项试验发现庞塞蒂技术优于传统技术,连续石膏固定和跟腱切断术后,庞塞蒂组参与者的平均皮拉尼总分低1.50分(95%置信区间0.72至2.28)。一项未报告初诊类型的试验发现,加速庞塞蒂治疗或标准庞塞蒂治疗之间没有差异。连续石膏固定结束时,标准组的平均皮拉尼总分比加速组低0.31分(95%置信区间 -0.40至1.02)。该试验未比较不良事件。缺乏证据支持不同的石膏固定产品或在庞塞蒂技术中添加A型肉毒毒素。也缺乏证据支持先天性马蹄内翻足的不同类型大手术、大手术后持续被动运动治疗或复发性或被忽视的先天性马蹄内翻足病例的治疗。大多数试验未报告不良事件。在评估连续石膏固定技术的试验中,不良事件包括石膏滑脱(需要更换)、石膏溃疡(受压部位)和皮肤刺激。手术操作后的不良事件包括感染和皮肤移植需求。
根据现有有限证据,与凯泰技术相比,庞塞蒂技术可能产生更好的短期结局。加速庞塞蒂技术可能与标准技术一样有效。由于验证结局指标使用有限且缺乏可用原始数据,我们无法从其他纳入试验中得出结论。未来的随机对照试验应解决这些问题。